LGALS3 and atherosclerosis: In summary, the data suggest that galectin-3 may act not only as an inflammatory marker but also as an active participant in the pathophysiology of atherosclerosis, indirectly influencing lipid metabolism—particularly in the context of low HDL-C and elevated non-HDL cholesterol.